CD22 Rekombinanter Antikörper
CD22 Rekombinant Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
230550C11
Kat-Nr. : 83303-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83303-1-PBS bindet in WB, IHC, Indirect ELISA CD22 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | Fusionsprotein |
Vollständiger Name | CD22 molecule |
Berechnetes Molekulargewicht | 95kd |
Beobachtetes Molekulargewicht | 130 kDa |
GenBank-Zugangsnummer | NM_001771.4 |
Gene symbol | CD22 |
Gene ID (NCBI) | 933 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein A purfication |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
CD22, also known as Siglec-2 (sialic acid binding Ig-like lectin 2) or BL-CAM (B-lymphocyte cell adhesion molecule), is a 130-140 kDa, B-cell restricted, type I transmembrane glycoprotein belonging to the immunoglobulin gene superfamily. The expression of CD22 is developmentally regulated. It is expressed at low levels in the cytoplasm of pro-B and pre-B cells and present on the cell surface only at mature stages of B-cell differentiation. Cell surface expression is lost during terminal differentiation into plasma cell and after B-cell activation. CD22 is an inhibitory receptor for B-cell receptor (BCR) signalling, preferentially binds to alpha-2,6-linked sialic acid and mediates B-cell B-cell interactions. It plays a crucial role in activation and differentiation of the B-cell.